Andrea S. James - 26 Mar 2026 Form 4 Insider Report for Insight Molecular Diagnostics Inc. (IMDX)

Reporting relationship: Chief Financial Officer
Issuer ticker: IMDX
Reported as of: 26 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Mar 2026, 17:29:10 UTC
Prior SEC filing: 13 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Andrea James

Key filing fact

Andrea S. James filed Form 4 for Insight Molecular Diagnostics Inc. (IMDX) on 30 Mar 2026.

Key facts

This page summarizes Andrea S. James's Form 4 filing for Insight Molecular Diagnostics Inc. (IMDX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 30 Mar 2026, 17:29.

Change

Previous filing in this sequence was filed on 13 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002027010 Primary reporting owner

James Andrea S.

Relationship: Chief Financial Officer
Address: C/O INSIGHT MOLECULAR DIAGNOSTICS INC., 2 INTERNATIONAL PLAZA, SUITE 510, NASHVILLE
Signature: /s/ Andrea James
Signature date: 30 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMDX transaction

Common Stock

Options Exercise

Transaction value
Shares: +28,302
Change %: +15%
Price
Shares after: 217,358
Date: 26 Mar 2026
Ownership: Direct
Footnotes: F1

IMDX transaction

Common Stock

Tax liability

Transaction value
Shares: -11,298
Change %: -5.2%
Price: $4.11^*
Shares after: 206,060
Date: 26 Mar 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMDX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -28,302
Change %: -25%
Price: $0.000000^*
Shares after: 84,905
Date: 26 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 28,302
Exercise price
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents vesting of restricted stock units ("RSUs") issued pursuant to the Company's 2018 Equity Incentive Plan. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs vested on the one-year anniversary of the effective date of grant.

Footnote F2

The reported disposition reflects shares withheld by the Company to cover required tax withholding obligations upon the vesting of the RSUs. The reporting person did not sell any shares.

Footnote F3

Each RSU has a value equal to one share of common stock. 25% of the RSUs vested on March 26, 2026 and the remaining 75% will vest in equal installments on each of the second-, third- and fourth-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date.